An SNRI (serotonin and norepinephrine reuptake inhibitor) is one of two major classes of medications used to treat clinical ...

Duloxetine is an antidepressant, with a specific batch having been recalled due to the presence of potentially cancer-causing ...

The bottles were distributed nationwide, including in Wisconsin, and received the FDA's second-most severe risk ...

More than 233,000 bottles of an antidepressant have been recalled by the FDA due to the presence of duloxetine posing the risk of cancer.

The Food and Drug Administration has recalled Duloxetine, a commonly prescribed antidepressant, due to fears it could contain ...

For diabetic peripheral neuropathic pain, the recommended dosage is 60 mg per day, although dosages of up to 120 mg daily have been studied. [25] Higher dosages do not have proven benefit and may ...

Rising Pharmaceuticals has voluntarily recalled over 233,000 bottles of Duloxetine in the US due to potential contamination ...

It's the generic for one of the most-prescribed drugs treating America's 21 million individuals managing depression. Here's ...

The recommended dosage of duloxetine is 40 80 mg daily, depending on the indication, preferably split into two doses per day. For the treatment of major depression, duloxetine has achieved ...

In three separate reports, the FDA said that various doses of duloxetine delayed-release capsules were recalled due to the ...

233,003 bottles of duloxetine have been recalled due to potentially containing high levels of cancer-causing impurities.